Dotmatics Resources for SLAS2023
Dotmatics, a global leader in R&D scientific software, offers comprehensive end-to-end solutions for biology, chemistry, and data management, highlighted at SLAS2023 with resources including Prism integration for enhanced data visualization and analysis, specialized biologics and small molecule discovery solutions, and downloadable overviews and eBooks to support innovation and efficiency in scientific research workflows.
What is Dotmatics?
Dotmatics is a global leader in R&D scientific software that connects science, data, and decision-making. By combining a workflow and data platform with best-of-breed applications, Dotmatics offers end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more.
- Download: Overview of Dotmatics
Prism by Dotmatics
Prism Integration: Templated Export of Dotmatics Data into Prism
Watch the Prism integration in action to see how the connection can accelerate research and expand visualization and analysis capabilities.
- Download: The Prism Integration Overview
- Download: The Prism Integration FAQ
The GraphPad Prism Solution
Learn how to achieve enhanced analysis and visualization for scientific research with GraphPad Prism.
- Download: The GraphPad Prism Solution
Biologics Discovery Resources
The Dotmatics Biology Solution provides end-to-end data management and analysis capabilities that fit into established research and development workflows.
- Download Overview: Biology Enterprise Solution
The pressure to innovate in biologics discovery is high. The eBook provides insights on overcoming this pressure with modern solutions to improve access to novel therapies.
- Download eBook: Optimizing Biologics Discovery
Small Molecule Discovery Resources
With increasing pressure to do more with less, companies need processes and technologies that drive innovation while controlling costs.
- Download Overview: Small Molecule Discovery Solution Overview
The eBook addresses common challenges in small molecule drug discovery, focusing on ensuring trustworthy and traceable data, improving productivity and collaboration, speeding up research, and reducing technical debt and total cost of ownership.
- Download eBook: Optimizing Small Molecule Discovery
Demo: Small Molecule Discovery in Dotmatics
Small Molecule Standard Demo Webinar
Speak with a Product Expert
Request to speak with a subject matter expert to discover how a unified solution can address specific needs.
Get a Demo of Dotmatics at SLAS Europe
Request a demo to see how a unified platform can accelerate research and help address specific challenges.
Get Started
Speak with a product expert to see how Dotmatics can enhance current practices.
Related
Trends and Needs in Chemicals and Materials Innovation
Dotmatics’ VP Alister Campbell highlights that despite diverse products, Chemicals and Materials R&D teams face common challenges like regulatory pressures, tight timelines, and budgets, necessitating digitalization strategies focused on quality data management and interoperability to streamline workflows, foster collaboration, and enable AI and machine learning applications that accelerate innovation and maintain competitiveness in this evolving market.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
SLAS2023 International Conference and Exhibition
The SLAS2023 International Conference and Exhibition, held February 25 to March 1 at the San Diego Convention Center, is a premier life sciences discovery and technology event where Dotmatics will showcase their innovative research solutions—including the Prism integration for no-code graph creation and streamlined Chemistry and Biology tools—at booth #721, offering attendees opportunities to engage with experts and explore cutting-edge scientific advancements.
Dotmatics Appoints Mike McKee as President and CEO
Dotmatics Ltd has appointed experienced technology CEO Mike McKee as its new President to accelerate the company's growth, scale its global team, double R&D investments, and lead integration efforts within Insightful Science's portfolio, succeeding founder Stephen Gallagher who will focus on strategic growth initiatives.
Dotmatics Chemicals & Materials Science Software Demo
Dotmatics offers a comprehensive, end-to-end scientific software platform that digitizes and automates lab functions for chemicals and materials research, integrating best-in-class tools like GraphPad Prism and SnapGene to help over 2 million researchers overcome data challenges, improve decision-making, and accelerate R&D workflows.
Four Moves Biotechs Can Make to Stay Competitive as Investor Confidence Shifts
As investor confidence in biotech has shifted from rapid, high-risk funding to more cautious, data-driven investment with longer timelines and stricter demands, biotechs must adapt by embracing innovative R&D platforms, demonstrating clear value through validated data and milestones, exploring flexible partnership models like co-development and joint ventures, and strategically managing growth to remain competitive in a market with tighter capital and evolving investor expectations.